# Amass Connector — AI Connector Amass Connector publishes 13 MCP tools to Claude and is listed in the ChatGPT apps directory. Marketplace availability, tool surface, verification tier, and what Node8 measured against the live endpoint. Source: https://node8.ai/ai-connectors/healthcare/amass/ --- [AI Connectors](https://node8.ai/ai-connectors/) · [Healthcare & Life Sciences](https://node8.ai/ai-connectors/healthcare/) # Amass Connector Search across six curated life sciences datasets Listed in ChatGPT and Claude · 13 published tools · Community-listed [ChatGPT listing](https://chatgpt.com/plugins/amass?open_in_app) [Claude connector docs](https://amass.tech/mcp) [amass.tech](https://amass.tech/) Overview ## What Amass Connector does Amass, from Amass Technologies ApS, opens six curated life sciences datasets to an assistant. BioMedCore holds more than 39 million peer reviewed papers from PubMed and PMC, TrialCore more than 575,000 trials drawn from ClinicalTrials.gov, and DrugCore about 22,000 harmonised drugs and molecules with modality, clinical stage, structure, synonyms, and the genes each one acts on. The remaining three cover regulation and biology. RegulatoryCore has over 7,000 FDA and EMA marketing authorisations with the underlying labels, reviews, SmPCs, and EPARs. GeneCore has around 43,000 human genes annotated for druggability, DepMap essentiality, target class, tractability, safety liabilities, and gnomAD constraint. PatentCore, still in preview, indexes life science patents with searchable full text, classification codes, assignees, inventors, and family links. Records can be filtered, retrieved in full, and followed across datasets back to the original source. ### Who it is for Life sciences researchers and analysts working across literature, trials, drugs, genes, regulation, and patents. ### What stands out Six datasets are cross linked, so a record in one can be followed through to related entries and back to the original source. Availability ## Where Amass Connector is listed Amass technologies Aps ships this on both marketplaces: Amass Connector is listed in the Claude connectors directory and in the ChatGPT apps directory, under the same publisher domain. Only 392 of the 3,150 products in this directory are listed in both marketplaces. One MCP server can serve both surfaces; what differs is each platform's listing and review process. ChatGPT listing ## In the ChatGPT apps directory Developer Amass Technologies ApS Filed under Productivity Listed since June 2026 Authentication Authenticates when installed Website [amass.tech](https://amass.tech) Policies published Privacy policy · Terms of service Official listing [Open in ChatGPT](https://chatgpt.com/plugins/amass?open_in_app) Snapshot August 2026 Claude listing ## In the Claude connectors directory Amass Connector publishes 13 tools to Claude. That is a mid-sized surface: 54.3% of the 1,253 Claude-listed connectors expose fewer. The median Claude-listed connector filed under Healthcare & Life Sciences publishes 6, so this one runs 7 tools above its bucket's median and ranks 7th of 51 by tool count. It falls in the 11-20 tools band, which holds 22.5% of the Claude directory. Amass Connector publishes a remote MCP endpoint. Claude connects to it over HTTP; there is nothing to install locally. Every connector in the Claude directory is remote, all 1,253 of them, so transport is not a differentiator there. Publisher Amass technologies Aps Verification Community-listed (61.5% of the Claude directory) Filed under Health & Life Sciences Endpoint `https://mcp.amass.tech/mcp` Documentation [Publisher setup docs](https://amass.tech/mcp) Published tools 13 · 11-20 tools band Depth rank in Healthcare & Life Sciences 7 of 51 Snapshot August 2026 Amass Connector is community-listed in the Claude directory, the tier 770 of 1,253 connectors sit in (61.5%). It is the default for a self-published server, and says nothing either way about quality. In the publisher's words ## How Amass technologies Aps describes it > \*\*The biomedical intelligence layer for AI\*\* Search and reason across 60M+ cross-linked life science records — including peer-reviewed publications, clinical trials, drugs, genes, regulatory approvals, and patents — from a single connector. Instead of searching individual databases, Amass gives Claude access to a unified biomedical knowledge layer where entities are linked across sources, enabling richer retrieval, evidence synthesis, and scientific reasoning with full source attribution. ## What you can do Use Amass to power workflows such as: - Scientific literature reviews - Drug and target discovery - Clinical trial landscape analysis - Regulatory intelligence (FDA & EMA) - Drug approval and label comparison - Patent landscape and freedom-to-operate research - Gene, target and biomarker exploration - Due diligence and competitive intelligence - AI agents that require grounded biomedical evidence ## Included \*Cores \*\*BioMedCore\*\* 40M+ peer-reviewed publications from PubMed and PubMed Central, including 3.6M+ with full text and 29M+ with abstracts. \*\*TrialCore\*\* 1.2M+ clinical trials from ClinicalTrials.gov and international registries (ChiCTR, CTRI, EU-CTR, JPRN, IRCT, and more), linked to drugs, diseases, publications and regulatory outcomes. \*\*DrugCore\*\* 22K+ harmonized drugs and molecules — including 5,200+ approved — with modality, mechanism of action, targets, development stage, synonyms, structures and ChEMBL relationships. \*\*RegulatoryCore\*\* 7K+ FDA and EMA approvals, backed by 466K+ parsed document sections — labels, SmPCs, EPARs, review documents and regulatory history. \*\*GeneCore\*\* 42K+ human genes enriched with target intelligence, druggability, clinical evidence, tractability, DepMap essentiality, safety liabilities and cross-links to drugs, trials and publications. \*\*PatentCore\*\* \*(Preview)\* 16M+ life science patents with full-text search, CPC/IPC classifications, patent families, assignees, inventors and chemical compounds. Quoted from the connector's own Claude directory listing as captured in August 2026. Node8 did not write it and does not vouch for it. Nearby ## Other Healthcare & Life Sciences connectors ### [AdisInsight](https://node8.ai/ai-connectors/healthcare/adisinsight/) Drug pipeline and clinical trial intelligence from AdisInsight Claude ### [BioSkepsis](https://node8.ai/ai-connectors/healthcare/bioskepsis/) Agentic life science literature reviews returned as cited briefs Claude ### [Clinical Trials](https://node8.ai/ai-connectors/healthcare/clinical-trials/) Search ClinicalTrials.gov by condition, sponsor, investigator or eligibility Claude ### [DrugBank](https://node8.ai/ai-connectors/healthcare/drugbank/) Pharmaceutical research data inside ChatGPT ChatGPT ### [Nexus](https://node8.ai/ai-connectors/healthcare/nexus/) Workout, meal and body weight logging inside the chat Claude ### [NyquistAI MedTech](https://node8.ai/ai-connectors/healthcare/nyquistai-medtech/) FDA medical device clearances, recalls and adverse events Claude [All 101 Healthcare & Life Sciences connectors](https://node8.ai/ai-connectors/healthcare/) This is an independent catalogue entry compiled by Node8 from Amass Connector's public marketplace listings as they stood in August 2026. Listing facts come from the marketplaces; the comparisons against the rest of the directory and any live-endpoint measurements are Node8's. Node8 is not affiliated with Amass technologies Aps, and inclusion here is not an endorsement. ## Want your company reachable inside ChatGPT and Claude? Node8 builds MCP servers end to end: deciding which tools are worth exposing, the authentication and permission model, the review submissions, and the onboarding that gets them used. One server serves ChatGPT, Claude, and Microsoft Copilot. [See how it works](https://node8.ai/mcp) Book a strategy session